<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04012996</url>
  </required_header>
  <id_info>
    <org_study_id>VAL-P-0022</org_study_id>
    <nct_id>NCT04012996</nct_id>
  </id_info>
  <brief_title>2-level Cervical Disc Replacement Comparing Prodisc C SK &amp; Vivo to Mobi-C</brief_title>
  <official_title>A Multi-Center, Prospective, Randomized Controlled Trial Comparing the Safety and Effectiveness of Prodisc® C SK and Prodisc® C Vivo to Mobi-C® Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centinel Spine</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centinel Spine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi-center, prospective, randomized, controlled comparison of the prodisc C SK and
      prodisc C Vivo to the control, a similar, legally marketed total disc replacement device in
      subjects with symptomatic cervical disc disease (SCDD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The clinical trial is to demonstrate that prodisc C SK and prodisc C Vivo are at least as
      safe and effective as a similar, currently marketed cervical disc prosthesis to treat
      symptomatic cervical disc disease (SCDD) in subjects at two contiguous levels from C3 to C7
      who are unresponsive to conservative management. Subjects will be randomized in a 2:1 ratio
      to either the two-level prodisc C SK or prodisc C Vivo device (investigational group) or to
      the two-level Mobi-C device (control group). Subjects will be followed for at least 2 years
      and up to 5 years. Subjects will be required to complete subject questionnaires, have X-rays
      and undergo neurological assessments during the follow up visits as specified in the
      protocol.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 5, 2019</start_date>
  <completion_date type="Anticipated">February 2028</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>multi-center, prospective, randomized, controlled comparison</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patient is blinded to their treatment randomization until after surgery.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Composite clinical success rate of the two-level prodisc C SK and prodisc C Vivo will be no worse than marketed cervical disc prosthesis (Mobi-C)</measure>
    <time_frame>24 months</time_frame>
    <description>Includes assessments such as NDI and neurological improvement.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">390</enrollment>
  <condition>Symptomatic Cervical Disc Disease</condition>
  <arm_group>
    <arm_group_label>Investigational</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two-level prodisc C SK and/or prodisc C Vivo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Two-level Mobi-C device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>prodisc C SK and/or Vivo</intervention_name>
    <description>Subjects will be randomized in a 2:1 ratio either to the two-level prodisc C SK or prodisc C Vivo device (investigational group) or to the two-level Mobi-C device (control group).</description>
    <arm_group_label>Investigational</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mobi-C Cervical Disc</intervention_name>
    <description>Subjects will be randomized in a 2:1 ratio either to the two-level prodisc C SK or prodisc C Vivo device (investigational group) or to the two-level Mobi-C device (control group).</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥18 and ≤69 years.

          2. Diagnosis of radiculopathy or myelopathy with radiculopathy of the cervical spine,
             with pain, paresthesias or paralysis in a specific nerve root distribution C3 through
             C7, including at least one of the following:

               1. Neck and/or arm pain (at least 30 mm on the 100 mm visual analogue scale [VAS]
                  scale).

               2. Decreased muscle strength of at least one level on the clinical evaluation 0 to 5
                  scale.

               3. Abnormal sensation including hyperesthesia or hypoesthesia; and/or

               4. Abnormal reflexes.

          3. Symptomatic cervical disc disease (SCDD) at two contiguous levels from C3 to C7.

          4. Radiographically determined pathology at the level to be treated correlating to
             primary symptoms including at least one of the following:

               1. Decreased disc height on radiography, computed tomography (CT), or magnetic
                  resonance imaging (MRI) in comparison to a normal adjacent disc.

               2. Degenerative spondylosis on CT or MRI.

               3. Disc herniation on CT or MRI.

          5. NDI Score of ≥ 30%

          6. Unresponsive to non-operative, conservative treatment (rest, heat, electrotherapy,
             physical therapy, chiropractic care and/or analgesics) for:

               1. Approximately six weeks from radiculopathy or myelopathy with radiculopathy
                  symptom onset; or

               2. Have the presence of progressive symptoms or signs of nerve root/spinal cord
                  compression despite continued non-operative, conservative treatment; or

               3. Sooner than 6 weeks for worsening symptoms of neurologic compromise.

        Exclusion Criteria:

          1. Have an active systemic infection or infection at the operative site.

          2. Have a history of or anticipated treatment for active systemic infection, including
             HIV or Hepatitis C.

          3. Have more than one immobile vertebral level between C1 to C7 from any cause including
             but not limited to congenital abnormalities and osteoarthritic &quot;spontaneous&quot; fusions.

          4. Have previous trauma to the C3 to C7 levels resulting in significant bony or
             disco-ligamentous cervical spine injury.

          5. Have had any prior spine surgery at the operative level(s).

          6. Have had a prior cervical TDR or fusion procedure at any level.

          7. Have axial neck pain in the absence of other symptoms of radiculopathy or myelopathy
             with radiculopathy justifying the need for surgical intervention.

          8. Have disc height less than 3 mm as measured from the center of the disc in a neutral
             position and disc height less than 20% of the anterior-posterior width of the inferior
             vertebral body.

          9. Have radiographic confirmation of severe facet joint disease or degeneration at any
             level.

         10. Have osteoporosis or is at increased risk of osteoporosis defined as a DEXA bone
             density measured T-score of ≤ -1.5. A DEXA performed within 24 months of the surgery
             date may be used to determine eligibility. For subjects without a DEXA within 24
             months of the surgery date a score ≥6 on either the SCORE or MORES requires a DEXA to
             determine eligibility.

         11. Have active malignancy that included a history of any invasive malignancy (except
             non-melanoma skin cancer), unless the subject had been treated with curative intent
             and there had been no clinical signs or symptoms of the malignancy for at least 5
             years.

         12. Have Symptomatic Cervical Disc Disease or significant cervical spondylosis at more
             than two levels.

         13. Have marked cervical instability on resting (neutral) lateral or flexion-extension
             radiographs demonstrated by:

               1. Translation ≥ 3.5 mm, and/or

               2. Greater than 11° angular difference to that of either adjacent level.

         14. Have known allergies to cobalt, chromium, molybdenum, titanium, nickel or
             polyethylene.

         15. Have segmental angulation of greater than 11° at treatment or adjacent levels.

         16. Have rheumatoid arthritis, lupus, or other autoimmune disease that affect the
             musculoskeletal system.

         17. Have congenital bony and/or spinal cord abnormalities that affect spinal stability.

         18. Have concomitant conditions requiring daily, high-dose oral and/or inhaled steroids.

         19. Have a Body Mass Index (BMI) &gt; 40 kg/m2.

         20. Taking medications known to potentially interfere with bone/soft tissue healing (e.g.,
             high-dose oral and/or inhaled steroids, immunosuppressant medication, chemotherapeutic
             agents).

         21. Have a current history of heavy smoking (more than one pack of cigarettes per day).

         22. Have had an epidural steroid injection within 14 days prior to surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonard I Voronov, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Centinel Spine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Angela Waltman</last_name>
    <phone>484-887-8867</phone>
    <email>a.waltman@centinelspine.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leonard Voronov, MD, PhD</last_name>
    <phone>484-887-8838</phone>
    <email>l.voronov@centinelspine.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Flagstaff Bone and Joint</name>
      <address>
        <city>Flagstaff</city>
        <state>Arizona</state>
        <zip>86001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Becca Patterson</last_name>
      <phone>928-440-5310</phone>
      <email>bpatterson@flagstaffboneandjoint.com</email>
    </contact>
    <investigator>
      <last_name>John M Hall, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Todd Lanman, MD, Inc.</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Devlin</last_name>
      <phone>310-385-7766</phone>
      <email>manager@spine.md</email>
    </contact>
    <investigator>
      <last_name>Todd Lanman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Cuellar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Doctors Outpatient Center for Surgery</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Babak Khandehroo, MD</last_name>
      <phone>909-641-1418</phone>
      <email>research@docspineortho.com</email>
    </contact>
    <contact_backup>
      <last_name>Stefanie Moertz, RN</last_name>
      <phone>530-400-6706</phone>
      <email>Stefanie@docs700.com</email>
    </contact_backup>
    <investigator>
      <last_name>Brian Perri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Khawar Siddique, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Albert Wong, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edward Nomoto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Hill, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Neel Anand, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rasouli Spine</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joel Sandoval</last_name>
      <phone>310-248-7363</phone>
      <email>js@rasoulispine.com</email>
    </contact>
    <investigator>
      <last_name>Alexandre Rasouli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ehsan Saadat, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Orthopaedic Institute</name>
      <address>
        <city>Temple Terrace</city>
        <state>Florida</state>
        <zip>33637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Debbi Warren, RN, CCRC</last_name>
      <phone>813-978-9700</phone>
      <phone_ext>6766</phone_ext>
      <email>dwarren@foreonline.org</email>
    </contact>
    <contact_backup>
      <last_name>Stephanie Carr</last_name>
    </contact_backup>
    <investigator>
      <last_name>John Small, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven Tresser, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana Spine Group</name>
      <address>
        <city>Carmel</city>
        <state>Indiana</state>
        <zip>46032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheetal Vinayek</last_name>
      <phone>443-812-4560</phone>
      <email>svinayek@indianaspinegroup.com</email>
    </contact>
    <investigator>
      <last_name>Rick Sasso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Smucker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orthopaedic Institute of Western Kentucky</name>
      <address>
        <city>Paducah</city>
        <state>Kentucky</state>
        <zip>42003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Vinson</last_name>
      <email>rvinson@orthopaedicinstitute.com</email>
    </contact>
    <investigator>
      <last_name>K. Brandon Strenge, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spine Institute of Louisiana</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus Stone, PhD</last_name>
      <phone>318-629-5585</phone>
      <email>mstone@louisianaspine.org</email>
    </contact>
    <contact_backup>
      <last_name>Carrie Warren</last_name>
      <phone>318-629-6336</phone>
      <email>cwarren@louisianaspine.org</email>
    </contact_backup>
    <investigator>
      <last_name>Pierce Nunley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eubulus Kerr, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Campbell, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Utter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rishi Wadhwa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Cavanaugh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacob Bruckner, MD</last_name>
      <phone>410-328-8808</phone>
      <email>jbruckner@som.umaryland.edu</email>
    </contact>
    <investigator>
      <last_name>Daniel Gelb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Cavanaugh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eugene Y Koh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven C Ludwig, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlie Sansur, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Georgetown University Hospital</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Pena</last_name>
      <email>jsp107@georgetown.edu</email>
    </contact>
    <investigator>
      <last_name>Faheem Sandhu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Motowski, RN, BSN</last_name>
      <phone>248-551-6679</phone>
      <email>lisa.motowski@beaumont.org</email>
    </contact>
    <investigator>
      <last_name>Jad Khalil, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeff Fischgrund, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Jacobson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Park, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Spine Center</name>
      <address>
        <city>Wayne</city>
        <state>New Jersey</state>
        <zip>07470</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Coban, PhD</last_name>
      <email>dan.coban@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Michelle Brenner, NP</last_name>
      <email>michbrenner@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Faloon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arash Emami, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ki Soo Hwang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kumar Sinha, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Langone Orthopedic Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brooke O'Connell, MS</last_name>
      <phone>646-794-8643</phone>
      <email>Brooke.Oconnell@nyulangone.org</email>
    </contact>
    <contact_backup>
      <last_name>Constance Maglaras</last_name>
      <email>Constance.Maglaras@nyulangone.org</email>
    </contact_backup>
    <investigator>
      <last_name>Aaron J Buckland, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Bendo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffrey Goldstein, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yong Kim, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Themistocles Protopsaltis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffrey Spivak, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>M3-Emerging Medical Resarch</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shandelle Parker</last_name>
      <phone>919-281-1698</phone>
      <email>sparker@wakeresearch.com</email>
    </contact>
    <contact_backup>
      <last_name>Sara Monday</last_name>
      <phone>919-781-2514</phone>
      <email>smonday@wakeresearch.com</email>
    </contact_backup>
    <investigator>
      <last_name>David Musante, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Dimmig, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ralph Liebelt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent Charity Medical Group</name>
      <address>
        <city>Solon</city>
        <state>Ohio</state>
        <zip>44139</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jayson Zadzilka, MS</last_name>
      <phone>330-205-1334</phone>
      <email>jzbiomedical@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Robert McLain, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Anderson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Hoffman, RN</last_name>
      <phone>717-531-0003</phone>
      <phone_ext>283063</phone_ext>
      <email>dhoffman1@pennstatehealth.psu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Leonard Kishel</last_name>
      <phone>717-531-0003</phone>
      <email>lkishel@pennstatehealth.psu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>George Reiter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Paul Kelleher, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael D Sather, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DFW Center for Spinal Disorders</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Longnecker</last_name>
      <phone>817-916-4685</phone>
      <email>rlongnecker@onri.us</email>
    </contact>
    <contact_backup>
      <last_name>Victor Kosmopoulos, PhD</last_name>
      <phone>817-916-4685</phone>
      <email>vkosmopoulos@onri.us</email>
    </contact_backup>
    <investigator>
      <last_name>Jason Tinley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Back Institute</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shannon Rusch, CCRC</last_name>
      <phone>972-608-5181</phone>
      <email>srusch@texasback.com</email>
    </contact>
    <contact_backup>
      <last_name>David Enenebeaku</last_name>
      <phone>972-608-5065</phone>
      <email>denenebeaku@texasback.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jessica Shellock, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Scott Blumenthal, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Guyer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Peloza, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jack Zigler, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Hisey, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Disc Replacement Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84088</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matt Allred, RN</last_name>
      <email>mrallredrn@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Armen Khachatryan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>July 5, 2019</study_first_submitted>
  <study_first_submitted_qc>July 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2019</study_first_posted>
  <last_update_submitted>July 21, 2020</last_update_submitted>
  <last_update_submitted_qc>July 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>symptomatic cervical disc disease</keyword>
  <keyword>SCDD</keyword>
  <keyword>neck pain</keyword>
  <keyword>radiculopathy</keyword>
  <keyword>myelopathy</keyword>
  <keyword>cervical spine pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Displacement</mesh_term>
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meloxicam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

